Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Abstract

Objective To assess the potential of anticholinergic drugs as a cause of non-degenerative mild cognitive impairment in elderly people. Design Longitudinal cohort study. Setting 63 randomly selected general practices in the Montpellier region of southern France. Participants 372 people aged > 60 years without dementia at recruitment. Main outcome measures Anticholinergic burden from drug use, cognitive examination, and neurological assessment. Results 9.2% of subjects continuously used anticholinergic drugs during the year before cognitive assessment. Compared with non-users, they had poorer performance on reaction time, attention, delayed non-verbal memory, narrative recall, visuospatial construction, and language tasks but not on tasks of reasoning, immediate and delayed recall of wordlists, and implicit memory. Eighty per cent of the continuous users were classified as having mild cognitive impairment compared with 35% of non-users, and anticholinergic drug use was a strong predictor of mild cognitive impairment (odds ratio 5.12, P = 0.001). No difference was found between users and non-users in risk of developing dementia at follow-up after eight years. Conclusions Elderly people taking anticholinergic drugs had significant deficits in cognitive functioning and were highly likely to be classified as mildly cognitively impaired, although not at increased risk for dementia. Doctors should assess current use of anticholinergic drugs in elderly people with mild cognitive impairment before considering administration of acetylcholinesterase inhibitors.

O uso da neuromodulação no tratamento das disfunções de eliminações

“…Uma metanálise 4 demonstrou que o efeito dos anticolinérgicos é bastante discutível frente aos placebos (efeito comparativo apenas 1,4 vezes melhor). Informações recentes em adultos atentam para defeitos intelectivos pelo uso de anticolinérgicos (o efeito prejudicial da oxibutinina nos mecanismos de memó-ria corresponderia em média a 10 anos de envelhecimento) 5 e síndromes demenciais Alzheimer-like, reversíveis com a retirada das drogas 6 . Não há estudos de boa qualidade técnica analisando os efeitos destas drogas sobre o cérebro humano infantil em processo de maturação.…”

Can Clinical Data Predict Progression to Dementia in Amnestic Mild Cognitive Impairment?

“…Finally, we did not assess formally for the use of particular medications with anticholinergic side effects, which have been found in 9% of MCI subjects. 100 We consider it unlikely that any of these would have provided definitive prognostication information however. The second caveat is the question of power.…”

Clarifying Delirium Management: Practical, Evidenced-Based, Expert Recommendations for Clinical Practice

“…29,40,59,61 Some that are particularly frequent in this population, such as constipation and urinary retention, are easily addressed. The most common causes of delirium found in patients with serious and/or advanced illness are fluid and electrolyte imbalances; medications (benzodiazepines, 52,53 opioids, 29,[53][54][55] steroids, 53,54,56 and anticholinergics 57,58 ); infections; hepatic or renal failure; hypoxia; and hematological disturbances. 29,59 Once the diagnosis of delirium is made, the assessment of any associated symptoms, likely underlying cause(s), the patient's functional status and prognosis, and patient and family goals of care will help to determine whether the delirium is potentially reversible or irreversible.…”